Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Johnson and Johnson
AstraZeneca
Boehringer Ingelheim
Baxter
McKinsey
Covington
Chubb
Healthtrust

Generated: April 23, 2018

DrugPatentWatch Database Preview

REGONOL Drug Profile

« Back to Dashboard

Which patents cover Regonol, and what generic alternatives are available?

Regonol is a drug marketed by Sandoz Inc and is included in one NDA.

The generic ingredient in REGONOL is pyridostigmine bromide. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the pyridostigmine bromide profile page.
Drug patent expirations by year for REGONOL
Pharmacology for REGONOL
Medical Subject Heading (MeSH) Categories for REGONOL
Synonyms for REGONOL
(1-methylpyridin-1-ium-3-yl) N,N-dimethylcarbamate bromide
(1-methylpyridin-1-ium-3-yl) N,N-dimethylcarbamate;bromide
1-Methyl-3-hydroxypyridinium bromide dimethylcarbamate
1-methyl-3-hydroxypyridiniumbromidedimethylcarbamate
101-26-8
3-(((dimethylamino)carbonyl)oxy)-1-methyl-pyridiniubromide
3-(((Dimethylamino)carbonyl)oxy)-1-methylpyridinium bromide
3-((Dimethylcarbamoyl)oxy)-1-methylpyridin-1-ium bromide
3-(Dimethylaminocarbonyloxy)-1-methylpyridinium bromide
3-(Dimethylcarbamoyloxy)-1-methylpyridinium Bromide
3-(Dimethylcarbamyloxy)-1-methylpyridinium bromide
3-(dimethylcarbamyloxy)-1-methylpyridiniumbromide
3-[(dimethylcarbamoyl)oxy]-1-methylpyridin-1-ium bromide
3-[[(Dimethylamino)carbonyl]oxy]-1-methylpyridinium bromide
3-{[(dimethylamino)carbonyl]oxy}-1-methylpyridinium bromide
3-Dimethylaminocarbonyloxy-N-methylpyridinium bromide
3-Dimethylcarbamoyloxy-1-methylpyridinium bromide;3-Dimethylcarbamoyloxy-1-methylpyridinium bromide
3-Hydroxy-1-methylpyridinium bromide dimethylcarbamate
3-Hydroxy-1-methylpyridinium bromide dimethylcarbamate (ester)
3-hydroxy-1-methylpyridiniumbromidedimethylcarbamate
3-hydroxy-1-methylpyridiniumbromidedimethylcarbamate(ester)
AB0013077
AB2000158
AC-8143
AC1L1P0M
AC1Q1RCO
AK162161
AKOS015895321
AN-937
ANW-41310
AS-13164
Bromure de pyridostigmine
Bromure de pyridostigmine [INN-French]
Bromuro de piridostigmina
Bromuro de piridostigmina [INN-Spanish]
Carbamic acid, dimethyl-, ester with 3-hydroxy-1-methylpyridinium bromide
CAS-101-26-8
CCG-40306
CCRIS 6798
CHEBI:8666
CHEMBL812
CPD000058605
CS-2148
CTK3J2505
D00487
D09KKU
Dimethylcarbamic acid ester of 3-hydroxy-1-methylpyridinium bromide
dimethylcarbamicacidesterof3-hydroxy-1-methylpyridiniumbromide
DR000766
DSSTox_CID_3540
DSSTox_GSID_23540
DSSTox_RID_77069
DTXSID9023540
EINECS 202-929-9
EU-0101035
FT-0081402
FT-0603307
H494
HMS1922M05
HMS2092P14
HMS2234D06
HMS3259M16
HMS3263O11
HMS3369P02
HMS3651G13
HMS500K09
HSDB 3924
HY-B0207A
I06-0719
Kalimin
Kalymin
KS-00000YPC
KSC492K0L
KVI301NA53
Lefaxin
LP01035
LS-329
MCULE-9535630272
Mestinon
Mestinon (TN)
Mestinon bromide
Mestinon;Regonol
MFCD00079283
MLS000028385
MLS001074080
MolPort-003-666-466
N,N-dimethyl(1-methyl(3-pyridyloxy))carboxamide, bromide
N,N-DIMETHYLAMINOFORMIC ACID 3-PYRIDINYL ESTER
NC00581
NCGC00015862-07
NCGC00094324-01
NCGC00094324-02
NCGC00094324-03
NCGC00094324-04
NCGC00261720-01
NE58261
NSC-679759
NSC-758435
NSC679759
NSC758435
Opera_ID_420
P 9797
P1339
Pharmakon1600-01503240
Piridostigmina bromuro
Piridostigmina bromuro [DCIT]
PubChem15395
pybr
Pyridinium, 3-(((dimethylamino)carbonyl)oxy)-1-methyl-, bromide
Pyridinium, 3-[[(dimethylamino)carbonyl]oxy]-1-methyl-, bromide
Pyridinium, 3-hydroxy-1-methyl-, bromide, dimethylcarbamate (ester)
Pyridinium, 3-hydroxyl-1-methyl-, bromide, dimethylcarbamate
Pyridostigmine (bromide)
PYRIDOSTIGMINE BROMIDE
Pyridostigmine bromide (JP17/USP/INN)
Pyridostigmine Bromide (Mestinon)
Pyridostigmine bromide [USAN:INN:BAN:JAN]
Pyridostigmine bromide [USP:INN:BAN:JAN]
Pyridostigmine bromide, European Pharmacopoeia (EP) Reference Standard
Pyridostigmine bromide, United States Pharmacopeia (USP) Reference Standard
Pyridostigmini bromidum
Pyridostigmini bromidum [INN-Latin]
Q-201644
Regonal
Ro 1-5130
RTR-000353
s1608
SAM002564227
SC-16827
SCHEMBL41147
SMR000058605
SPECTRUM1503240
SR-01000003072
SR-01000003072-2
ST24041332
ST51015114
Tox21_111266
Tox21_111266_1
Tox21_501035
TR-000353
UNII-KVI301NA53
Z1541632810

US Patents and Regulatory Information for REGONOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz Inc REGONOL pyridostigmine bromide INJECTABLE;INJECTION 017398-001 Approved Prior to Jan 1, 1982 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cerilliant
Deloitte
McKinsey
UBS
Fuji
Harvard Business School
Chubb
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.